Moclobemide in the prophylactic treatment of migraine

European Neurology

Volumn 36, Issue 2, 1996, Pages 109-110

  Meienberg, Otmar ^a   Amsler, Felix ^b  

^a Neurological Practice   (Switzerland)

^b Roche Pharma Schweiz AG   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

MOCLOBEMIDE; MONOAMINE OXIDASE INHIBITOR;

ARTICLE; CLINICAL ARTICLE; DRUG EFFICACY; GASTROINTESTINAL SYMPTOM; HUMAN; INSOMNIA; MIGRAINE; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

ANALGESICS; BENZAMIDES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; LONG-TERM CARE; MALE; MIGRAINE DISORDERS; MOCLOBEMIDE; RECURRENCE; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 0030044756     PISSN: 00143022     EISSN: 14219913     Source Type: Journal    
DOI: 10.1159/000117221     Document Type: Article

References (10)

1. Olesen J: A review of current drugs for migraine. J Neurol 1991 ;238(suppl 1):S23-S27.
2. Raskin NH: Acute and prophylactic treatment of migraine: Practical approaches and pharmacologic rationale. Neurology 1993:43(suppl 3): S39-S42.
3. Baurnel B: Migraine: A pharmacologic review with newer options and delivery modalities. Neurology 1994;44(suppl 3):S13-S17.
4. Fitton A, Faulds D, Goa KL: Moclobemide. A review of its pharmacological properties and therapeutic use in depressive illness. Drugs 1992;43: 561-596.
5. Freeman H: Moclobemide. Lancet 1993:342:1528-1532.
6. Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 1988;8(suppl 7):9-96.
7. Silberstein SD, Silberstcin MM: New concepts in the pathogenesis of headache. Pain Management 1990;3:334-342.
8. Lipton RB, Stewart WF: The epidemiology of migraine. Eur Neurol 1994; 34(suppl 2):6-11.
9. Claman JM: The potential effectiveness of moclobemide. the new monoamine oxidase inhibitor, in the prophylaxis of migraine. Headache 1993: 33:339.
10. Stewart WF, Lipton RB: The economic and social impact of migraine. Eur Neurol 1994:34(suppl 2):12-17.